New radiation treatment method merciful for children with brain tumors

Share this article:

Newer radiation therapy techniques could reduce the harmful adverse effects of brain radiation therapy in children. For children who undergo brain radiation therapy, permanent neurocognitive adverse effects are a significant risk. These risks arise because the radiation often encounters healthy tissue, which reduces the formation of new cells, particularly in the hippocampus. The hippocampus is the part of the brain involved in memory and learning.

The newer techniques use proton beams. While traditional x-ray radiation and electron radiation pass right through the body and so have the potential to harm healthy tissue, the energy in a proton beam can be varied so that it reaches a predetermined depth. The protons can be concentrated to the actual tumor with a minimum dose to healthy tissue, which reduces the risk of adverse effects.

A model study tested how the harmful adverse effects could be reduced by using newer techniques. The study was based on a number of pediatric patients who had undergone conventional radiation treatment for medulloblastoma, which is a form of brain tumor that almost exclusively affects children. The study simulated treatment plans using proton therapy techniques and newer proton therapy techniques.

Four techniques were compared: standard opposing fields, intensity-modulated radiotherapy, intensity-modulated arc therapy, and intensity-modulated proton therapy. While maintaining at least 95% of the prescribed dose in 95% of the whole-brain target volume, the mean dose to the hippocampus and subventricular zone could be limited to 88.3% with intensity-modulated radiotherapy, 77.1% with intensity-modulated arc therapy, and 42.3% with intensity-modulated proton therapy. These newer techniques reduced the estimated risks for developing memory impairment to less than half that with standard opposing fields.

The study concluded that these techniques are feasible, and that they lower the risk of long-term neurocognitive adverse effects. Intensity-modulated proton therapy achieved the most sparing of the hippocampus and subventricular zone, so it is an attractive option to be tested in a prospective clinical trial.

“This could mean a better quality of life for children who are forced to undergo brain radiation therapy,” says Malin Blomstrand, first author and doctoral student at the Sahlgrenska Academy at the University of Gothenburg. This study is published in Neuro-Oncology (2012; doi:10.1093/neuonc/nos120).
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Web Exclusives

Improved tyrosine kinase inhibitor (TKI) selectively activates in tumor tissue, minimizing side ...

A new strategy developed by an interdisciplinary team of researchers aims to reduce the side effects connected to use of tyrosine kinase inhibitors (TKIs).

Prior cancer exclusion criteria may stymie potential of lung cancer clinical trials

A history of prior cancer can exclude many individuals from participation in clinical trails related to lung cancer, even when the prior cancer is unlikely to interfere with treatment outcomes.

Better adherence to guidelines for safe handling of antineoplastic drugs is needed

Recommended safe handling practices for workers who administer antineoplastic drugs in health care settings are not always followed, according to a new study.